文献速递慢性静脉疾病

穿通静脉消融后静脉性溃疡完全愈合不依赖治疗方式

Complete Venous Ulceration Healing after Perforator Ablation Does Not Depend on Treatment Modality.
PubMed 文献 · Ann Vasc Surg · 2020-06-27

该多中心回顾性研究纳入232例接受穿通静脉(IPV)消融的静脉性溃疡(VLU)患者,比较激光、射频和泡沫硬化剂三种方式。结果显示三组1年愈合率无差异(P=0.18),后续手术次数也无差异(P=0.47)。

要点

  • IPV消融方式(EVLT、RFA、UGFS)不影响VLU的1年愈合率。
  • 不同消融方式后续手术次数无显著差异。
  • RFA组患者年龄更大、男性更多、抗凝比例更高。

核心结论

  • 穿通静脉消融方式与静脉性溃疡愈合率及后续手术次数无关。

研究设计与样本

  • 多中心回顾性队列研究,纳入11个医疗中心2013-2017年接受IPV治疗的232例VLU成人患者。

主要发现

  • 三组1年溃疡愈合率无差异(P=0.18)。
  • 后续手术次数无差异(P=0.47)。
  • RFA组年龄更大(62±14岁 vs EVLT 59±14岁 vs UGFS 52±9岁,P=0.01)。
  • RFA组男性比例更高(68% vs 41% vs 64%,P<0.001)。
  • RFA组抗凝比例更高(36% vs 18% vs 14%,P=0.005)。

临床怎么用

  • 选择IPV消融方式时可依据患者特征和设备条件,无需担心愈合率差异。

局限性

  • 回顾性设计,样本量有限,UGFS组仅14例。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Venous leg ulceration (VLU) represents the most advanced form of chronic venous insufficiency (CVI). Persistent VLU that fails to respond to noninvasive treatment requires a minimally invasive endovascular treatment, which may include chemical (ultrasound-guided foam sclerotherapy [UGFS]) and thermal ablation (endovenous laser therapy [EVLT] or radiofrequency ablation [RFA]) targeting incompetent veins. Current guidelines suggest ablation of incompetent perforating veins (IPVs) juxtaposed to active or healed VLU; however, the ideal treatment modality is unknown. We hypothesize that similar to incompetent superficial vein treatment options therapies, VLU healing will be equivalent across minimally invasive IPV treatment options. METHODS: Using the Vascular Low Frequency Disease Consortium, adults with VLU across 11 medical centers were retrospectively reviewed (2013-2017). We included those who underwent IPV therapies. The primary outcome was complete ulcer healing over time compared with cumulative hazard curves, log-rank testing, and multivariable Cox proportional hazard regression. Secondary outcomes included number of subsequent procedures, which were compared using negative binomial regression. RESULTS: Of the 832 adults with VLU, 158 (19%) were exclusively treated conservatively, and 232 (28%) underwent index treatment for IPV and constitute the full and final cohort. The mean age was 60 ± 14 years, 57% were men, and the mean ulcer area was 3.0 cm2 (interquartile range, 1-6 cm2). Ninety-one (39%) were treated with EVLT, 127 (55%) RFA, and 14 (6%) UGFS. Patients treated with RFA were older (RFA 62 ± 14 years; EVLT 59 ± 14 years; UGFS 52 ± 9 years; P = 0.01), more likely to be men (RFA 68%, n = 86; EVLT 41%, n = 37; UGFS 64%, n = 9; P < 0.001), with a higher frequency of anticoagulation (RFA 36%, n = 46; EVLT 18%, n = 16; UGFS 14%, n = 2; P = 0.005). VLU did not significantly differ in size between groups (RFA 6.2 ± 8; EVLT 4.2 ± 5.4; UGFS 6.1 ± 8; P < 0.001). There were no differences in 1-year ulcer healing rates between groups (P = 0.18). The number of subsequent procedures did not differ by treatment modality (P = 0.47). CONCLUSIONS: This multi-institutional retrospective study does not demonstrate any association of IPV treatment modality with differing rates of VLU healing or number of subsequent procedures.

来源:Ann Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Reitz KM, Salem K, Mohapatra A, et al. Complete Venous Ulceration Healing after Perforator Ablation Does Not Depend on Treatment Modality. Ann Vasc Surg. 2020. PMID: 32603845. doi:10.1016/j.avsg.2020.06.051

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。